These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 5694737)
1. [Retraction of the eyelids of endocrine origin treated with guanethidine (Ismelin) eyedrops]. Kjer P Ugeskr Laeger; 1968 Jan; 130(1):10-3. PubMed ID: 5694737 [No Abstract] [Full Text] [Related]
2. [Action of 5 per cent guanethidine sulfate (ismeline) eye drops on lid retraction during Basedow's disease]. Storch J Ann Ocul (Paris); 1971 Jun; 204(6):627-44. PubMed ID: 5109312 [No Abstract] [Full Text] [Related]
3. [Effect of guanethidine eyedrops on the ocular manifestations of Basedow's disease]. Berkman N; Joseph E Arch Ophtalmol Rev Gen Ophtalmol; 1971; 31(8):617-28. PubMed ID: 4256931 [No Abstract] [Full Text] [Related]
4. Use of guanethidine eye drops in dysthyroid lid retraction. Martin B; Jay B Proc R Soc Med; 1969 Jan; 62(1):18-9. PubMed ID: 5763459 [No Abstract] [Full Text] [Related]
5. [Effectiveness of guanethidine in preventing the retraction of the upper lid in Graves' disease]. Chwirot R; Gliński J Klin Oczna; 1972; 42(3):883-4. PubMed ID: 5067657 [No Abstract] [Full Text] [Related]
6. Guanethidine drops in thyroid eye disease. Millar GT Trans Ophthalmol Soc U K (1962); 1969; 88():677-9. PubMed ID: 5272285 [No Abstract] [Full Text] [Related]
7. Topical guanethidine therapy for endocrine lid retraction. Gay AJ; Wolkstein MA Arch Ophthalmol; 1966 Sep; 76(3):364-7. PubMed ID: 5952755 [No Abstract] [Full Text] [Related]
8. Dysthyroid eye disease. A trial of guanethidine eye drops. Bowden AN; Rose FC Br J Ophthalmol; 1969 Apr; 53(4):246-51. PubMed ID: 4889097 [No Abstract] [Full Text] [Related]
9. Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction. Cant JS; Lewis DR Br J Ophthalmol; 1969 Apr; 53(4):239-45. PubMed ID: 5818670 [No Abstract] [Full Text] [Related]
10. Topical sympatholytic therapy for pathologic lid retraction. Gay AJ; Salmon ML; Wolkstein MA Arch Ophthalmol; 1967 Mar; 77(3):341-4. PubMed ID: 6019554 [No Abstract] [Full Text] [Related]
12. [Ocular manifestations of Basedow's disease and local administration of guanethidine]. Berkman N; Joseph E Presse Med (1893); 1971 Jan; 79(3):83-6. PubMed ID: 5107433 [No Abstract] [Full Text] [Related]
13. Treatment of dysthyroid ophthalmopathy with local guanethidine. Cant JS; Lewis DR; Harrison MT Br J Ophthalmol; 1969 Apr; 53(4):233-8. PubMed ID: 5818669 [No Abstract] [Full Text] [Related]
15. [The effects of the Sanotensin eyedrops]. Csigány A Orv Hetil; 1968 Jul; 109(27):1487-8. PubMed ID: 5719102 [No Abstract] [Full Text] [Related]
16. Botulinum toxin type A in upper lid retraction of Graves' ophthalmopathy. Ebner R J Clin Neuroophthalmol; 1993 Dec; 13(4):258-61. PubMed ID: 8113438 [TBL] [Abstract][Full Text] [Related]
17. Mueller's muscle: to relax or to incise. Haddad HM Metab Pediatr Syst Ophthalmol (1985); 1995; 18(1-4):15-8. PubMed ID: 9064490 [TBL] [Abstract][Full Text] [Related]
18. [Ismelin in the treatment of glaucoma]. Wolter-Czerwińska H; Nowak A; Taracha A Klin Oczna; 1973 Feb; 43(2):149-53. PubMed ID: 4805033 [No Abstract] [Full Text] [Related]
19. Surgical correction of upper eyelid retraction. Liu D Ophthalmic Surg; 1993 May; 24(5):323-7. PubMed ID: 8043038 [TBL] [Abstract][Full Text] [Related]